Product Code: ETC13399801 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Blood Screening Market was valued at USD 2.8 Billion in 2024 and is expected to reach USD 4.9 Billion by 2031, growing at a compound annual growth rate of 15.50% during the forecast period (2025-2031).
The Global Blood Screening Market is a rapidly growing sector driven by the increasing demand for blood donations, rising prevalence of infectious diseases, and advancements in technology. Key players in the market offer a wide range of screening products and services to detect infectious diseases such as HIV, hepatitis, and syphilis in donated blood. The market also includes screening for blood transfusion compatibility and non-infectious diseases like cancer markers. North America and Europe dominate the market due to stringent regulations and high awareness about blood safety. However, the Asia-Pacific region is witnessing significant growth due to improving healthcare infrastructure and increasing investments in healthcare. The market is characterized by intense competition, technological innovations, and strategic collaborations among key players to expand their product portfolios and global presence.
The Global Blood Screening Market is experiencing rapid growth due to increasing demand for blood donations, rising prevalence of infectious diseases, and advancements in screening technologies. Key trends include a shift towards automated and high-throughput screening processes, adoption of nucleic acid testing for improved accuracy, and increasing focus on expanding screening capabilities to include a wider range of pathogens. Opportunities in the market lie in the development of innovative screening solutions, expansion into emerging markets with high disease burden, and partnerships with healthcare providers to improve access to screening services. With the growing emphasis on blood safety and the need for efficient screening processes, the Global Blood Screening Market is poised for sustained expansion in the coming years.
The Global Blood Screening Market faces several challenges, including stringent regulatory requirements, high costs associated with advanced screening technologies, and the risk of false positive or false negative results. Regulatory authorities around the world have established strict guidelines for blood screening procedures to ensure the safety of blood transfusions and minimize the risk of transmitting infectious diseases. This has led to increased pressure on companies to comply with these regulations, which can be time-consuming and costly. Additionally, the adoption of newer technologies such as nucleic acid testing and next-generation sequencing has brought about cost challenges for healthcare facilities, particularly in developing countries. Finally, the occurrence of false results can have serious implications on patient care and may lead to unnecessary treatments or delays in diagnosis. Addressing these challenges requires continuous innovation, investment in research and development, and collaboration among industry stakeholders.
The Global Blood Screening Market is primarily driven by the increasing demand for blood donations and transfusions, rising prevalence of infectious diseases such as HIV/AIDS and hepatitis, and the implementation of stringent regulations for blood safety. Technological advancements in blood screening techniques, growing awareness about the importance of blood screening in healthcare settings, and the rising number of blood banks and screening centers worldwide are also significant drivers of market growth. Additionally, the increasing healthcare expenditure, improving healthcare infrastructure in developing countries, and the emphasis on early detection and prevention of diseases further contribute to the expansion of the blood screening market on a global scale.
Government policies related to the Global Blood Screening Market typically focus on ensuring the safety and quality of blood products, as well as preventing the transmission of infectious diseases through blood transfusions. Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in the EU have established guidelines and standards for blood screening tests and technologies, including requirements for screening for diseases such as HIV, hepatitis, and other pathogens. These policies aim to protect public health by reducing the risk of transfusion-transmitted infections and ensuring the reliability of blood screening procedures. Additionally, government agencies may also provide funding or support for research and development in blood screening technologies to further improve safety and efficiency in the industry.
The Global Blood Screening Market is poised for significant growth in the coming years due to increasing blood donations, rising prevalence of infectious diseases, and stringent regulatory requirements for blood safety. Technological advancements in blood screening technologies, such as nucleic acid testing and automation, are expected to drive market expansion. Additionally, the growing demand for donated blood in emerging economies and the rising awareness about transfusion-transmitted infections are likely to fuel market growth. However, challenges such as high costs associated with advanced blood screening technologies and the lack of skilled professionals in certain regions may hinder market development. Overall, the Global Blood Screening Market is anticipated to witness steady growth in the foreseeable future, presenting opportunities for key market players to innovate and expand their product offerings.
The Asia Pacific region is expected to witness the highest growth in the Global Blood Screening Market due to increasing healthcare expenditure, rising awareness about blood safety, and a growing number of blood transfusions. North America holds a significant market share owing to advanced healthcare infrastructure, stringent regulatory guidelines, and a high prevalence of blood-borne diseases. Europe is also a key market with a strong focus on blood safety measures and technological advancements in screening techniques. The Middle East and Africa region is experiencing steady growth driven by increasing demand for blood screening services and rising healthcare investments. Latin America is poised for growth due to improving healthcare facilities, increasing blood donation drives, and government initiatives to enhance blood safety standards.
Global Blood Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Blood Screening Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Blood Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Global Blood Screening Market - Industry Life Cycle |
3.4 Global Blood Screening Market - Porter's Five Forces |
3.5 Global Blood Screening Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Blood Screening Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Blood Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Global Blood Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Blood Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Blood Screening Market Trends |
6 Global Blood Screening Market, 2021 - 2031 |
6.1 Global Blood Screening Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Blood Screening Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.3 Global Blood Screening Market, Revenues & Volume, By Reagents & Kits, 2021 - 2031 |
6.2 Global Blood Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Blood Screening Market, Revenues & Volume, By Molecular Tests, 2021 - 2031 |
6.2.3 Global Blood Screening Market, Revenues & Volume, By Serology Tests, 2021 - 2031 |
6.3 Global Blood Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Blood Screening Market, Revenues & Volume, By Independent Clinical Laboratories, 2021 - 2031 |
6.3.3 Global Blood Screening Market, Revenues & Volume, By Hospital-based Laboratories, 2021 - 2031 |
6.3.4 Global Blood Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Blood Screening Market, Overview & Analysis |
7.1 North America Blood Screening Market Revenues & Volume, 2021 - 2031 |
7.2 North America Blood Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Blood Screening Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Blood Screening Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Blood Screening Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Blood Screening Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Blood Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 North America Blood Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Blood Screening Market, Overview & Analysis |
8.1 Latin America (LATAM) Blood Screening Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Blood Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Blood Screening Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Blood Screening Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Blood Screening Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Blood Screening Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Blood Screening Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Blood Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.5 Latin America (LATAM) Blood Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Blood Screening Market, Overview & Analysis |
9.1 Asia Blood Screening Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Blood Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Blood Screening Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Blood Screening Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Blood Screening Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Blood Screening Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Blood Screening Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Blood Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.5 Asia Blood Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Blood Screening Market, Overview & Analysis |
10.1 Africa Blood Screening Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Blood Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Blood Screening Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Blood Screening Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Blood Screening Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Blood Screening Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Blood Screening Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Blood Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.5 Africa Blood Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Blood Screening Market, Overview & Analysis |
11.1 Europe Blood Screening Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Blood Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Blood Screening Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Blood Screening Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Blood Screening Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Blood Screening Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Blood Screening Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Blood Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.5 Europe Blood Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Blood Screening Market, Overview & Analysis |
12.1 Middle East Blood Screening Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Blood Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Blood Screening Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Blood Screening Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Blood Screening Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Blood Screening Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Blood Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.5 Middle East Blood Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Blood Screening Market Key Performance Indicators |
14 Global Blood Screening Market - Export/Import By Countries Assessment |
15 Global Blood Screening Market - Opportunity Assessment |
15.1 Global Blood Screening Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Blood Screening Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Blood Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.4 Global Blood Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Blood Screening Market - Competitive Landscape |
16.1 Global Blood Screening Market Revenue Share, By Companies, 2024 |
16.2 Global Blood Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |